A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : LMWH

Search Conditions:
Search Keyword : LMWH
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: LMWH
Appearance Frequency: 3876 time(s)
Long forms: 26

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
low molecular weight heparin
(3828 times)
Vascular Diseases
(887 times)
VTE (847 times)
UFH (772 times)
DVT (528 times)
0 [Long-term treatment of venous thromboembolism in patients with cancer].
low molecular heparin
(9 times)
Thrombosis
(2 times)
ACCP (1 time)
aPDAC (1 time)
ATTE (1 time)
1992 [Prevention of thromboembolic complications in surgery].
low-molecular-weight heparin derivative
(6 times)
Toxicology
(2 times)
fMLP (1 time)
GAGs (1 time)
LST (1 time)
1999 Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells.
low molecular weight fractions of heparin
(4 times)
Biochemistry
(1 time)
anti-Xa (1 time)
APTT (1 time)
ATH (1 time)
1983 Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis.
low-molecular-weight hydrogel
(4 times)
Chemistry
(3 times)
DEX-P (1 time)
FTIR (1 time)
MGC (1 time)
2007 Structure and properties of low molecular weight amphiphilic peptide hydrogelators.
LMWH group
(3 times)
Anesthesiology
(1 time)
ACT (1 time)
MICS (1 time)
PVST (1 time)
2007 Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
low molecular weight hyaluronan
(2 times)
Neurology
(2 times)
HMWH (2 times)
CD44 (1 time)
HA (1 time)
2018 CD44 Signaling Mediates High Molecular Weight Hyaluronan-Induced Antihyperalgesia.
low-molecular-weight heparin or heparinoid
(2 times)
Neurology
(1 time)
CI (2 times)
DVT (1 time)
RR (1 time)
2007 Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles.
enoxaparin--low-molecular-weight heparin
(1 time)
Metabolism
(1 time)
DEXA (1 time)
MRI (1 time)
PPO (1 time)
2015 Postpartum osteoporosis and vertebral fractures in two patients treated with enoxaparin during pregnancy.
10  LMW heparins
(1 time)
Hematology
(1 time)
CS (1 time)
CV (1 time)
UH (1 time)
1990 Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.
11  LMWH treatment
(1 time)
Allergy and Immunology
(1 time)
IL-6 (1 time)
MBP (1 time)
PE (1 time)
2012 Protective effect of low-molecular-weight heparin on pancreatic encephalopathy in severe acute pancreatic rats.
12  LMWH-LDHs
(1 time)
Biomedical Engineering
(1 time)
LDHs (1 time)
SMC (1 time)
2010 Enhanced effects of low molecular weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle cells.
13  LMWH-p
(1 time)
General Surgery
(1 time)
DVT (1 time)
2014 Administration of enoxaparin 24h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention.
14  low molecular weight fractions
(1 time)
Nephrology
(1 time)
--- 1994 [Instantaneous clearances: standard heparin versus low molecular weight heparin].
15  Low molecular weight heparin nanoparticles
(1 time)
Chemistry
(1 time)
DOX (1 time)
GA (1 time)
HPC (1 time)
2017 Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
16  low molecular weight heparin parenteral anticoagulant
(1 time)
Health Services
(1 time)
VKA (1 time)
VTE (1 time)
2019 Total costs of treating venous thromboembolism: implication of different cost perspectives in a Danish setting.
17  Low Molecular Weight Heparin prophylaxis
(1 time)
Vascular Diseases
(1 time)
CAT (1 time)
CCC (1 time)
MP (1 time)
2016 Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
18  Low Molecular Weight Hydrogels
(1 time)
Biomedical Engineering
(1 time)
LMWHs (1 time)
2020 New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product.
19  low weight molecular heparin
(1 time)
Geriatrics
(1 time)
AF (1 time)
CGA (1 time)
OAC (1 time)
2016 The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation.
20  low-molecular-weight analogue
(1 time)
Nephrology
(1 time)
--- 1993 Low-molecular-weight heparin (LMWH): influence on blood lipids in patients on chronic haemodialysis.
21  low-molecular-weight forms
(1 time)
Molecular Biology
(1 time)
FXa (1 time)
2006 The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors.
22  low-molecular-weight heparin therapy
(1 time)
CTV (1 time)
CVT (1 time)
GOS (1 time)
2019 Cerebral Venous Thrombosis at High Altitude: A Retrospective Cohort of Twenty-one Consecutive Patients.
23  low-molecular-weight-- heparins being
(1 time)
Legislation, Drug
(1 time)
--- 2004 [Assessing the use of low-molecular-weight heparins fo venous thromboembolism prophylaxis in internal medicine patients].
24  low-MW-heparins
(1 time)
Medicine
(1 time)
S-NACH (1 time)
2018 Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway.
25  lower molecular weight
(1 time)
Medicine
(1 time)
UFH (1 time)
1996 [New developments in anticoagulation with heparin; a short review.].
26  ultra-low-molecular-weight heparin
(1 time)
Vascular Diseases
(1 time)
s.c (1 time)
2014 Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin.